This announcement is a separate document:
上海医药集团股份有限公司2024年半年度报告全文
Full text of Shanghai Pharma Group Co., Ltd.'s 2024 interim report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
17:32
European Central Bank Governing Council member and Governor of the French Central Bank Villeroy: If the pace of interest rate cuts is stable, there is no need to increase the scale.
17:32
Zhejiang Nhu: Net income is expected to grow by 114.48%-129.27% year-on-year in 2024.
Zhejiang Nhu-0.27%
17:32
Inner Mongolia Yitai Coal: The concerted parties of the controlling shareholder plan to increase their Shareholding by 0.08 billion USD to 0.16 billion USD.
Inner Mongolia Yitai Coal+0.50%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.